المعالجة بالميتوتركسات في الحمل الهاجر

Authors

  • ميسون ديوب

Abstract

This study was conducted at Tishreen Hospital University in the department of obstetrics and gynecology between 1/1/2016 -1/1/2018 on the patients of symptoms of pregnancy, which classified depending on Fernandez score, The number of patients was 50 patients. We have mad for each patient the following

1-   Climical history

2-   Vagimal Echography

3-    BHCG

4-   Proqestme imserwe

5-   CBC

6-   Amalqsisol lives and kidmy

We gave a unique dose of methotrexate 1 mg/ kg  for each patient.after one week we give another close if   the number of  BHCG still high in the 4th and 7th day,we observed if   the number of  BHW in day 2-4-6 then after  every week until we have the value of BHCG = negative plow Blood analysis after one week .  The results were as follows:1-   The percentage of multipara patient was 84% ​​and the age of  the patients were most between 20-30 years2-   The percentage of the patients with  who  cesarean section was 60% and the percentage of one  abortion least was 48%3-   After the treatment of methotrexate  the pain  reduced in  78% and the bleeding reduced  in 70% 4-   We were forced to repent the does one  after week in 16% on the cases 5-   The treatment of  methotrexate  was not succeed in 8% of the cases6-   We did not pimd  any side effects on this treatment with one dose in 100% of the patients  

أجريت هذه الدراسة في قسم التوليد وأمراض النساء ما بين 1/1/2016 و1/1/2018 على المريضات المقبولات بأعراض حمل هاجر وتم تحديد المريضات المؤهلات للعلاج الدوائي وذلك حسب مشعر فرنانديز كان عدد المريضات 50 مريضة. حيث تم أخد قطعة مفصلة لكل مريضة وتم اجراء الايكو المهبلي مع معايرات BHCG  وعيار البروجسترون المصلي – تعداد وصيغة  – وظائف الكبد والكلية

تم إعطاء جرعة وحيدة  1mg /كغ عضلي من الميتوتركسات , تعاد الجرعة بعد أسبوع اذا كانت قيم BHCG لم تنخفض بين اليوم الرابع والسابع , مراقبة  BHCG في اليوم 2-4-6 ثم كل أسبوع حتى سلبيه BHCG اجراء تحاليل دموية بعد أسبوع

وكانت النتائج كالتالي:

1-  كانت نسبة الولودات في دراستنا 84% وأغلب المريضات كانت في الفئة العمرية بين 20-30 سنه

2-  كانت نسبة المريضات اللواتي خضعن للعمل القيصري 60% من كان لديهن سوابق اجهاض 48%

3-  نتائج المعالجة بعد إعطاء جرعة الميتوتركسات هي تراجع الألم بنسبة 78% والنزف بنسبة 70%

4-  تم إعادة الجرعة بعد أسبوع لدى 16% من المريضات

5-  لم تنجح المعالجة الدوائية لدى 4 مريضات أي بنسبة 8%

6-  بالمراقبات المخبرية لم يلاحظ وجود أي اثار جانبية أو اسمية للميتوتركسات

Downloads

Published

2019-08-28

How to Cite

1.
ديوب م. المعالجة بالميتوتركسات في الحمل الهاجر. Tuj-hlth [Internet]. 2019Aug.28 [cited 2024Apr.30];41(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/8954

Issue

Vol. 41 No. 4 (2019): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)